← Leaderboards
Curt H Hagedorn
Emory University
$2,805,834
Attributed
$2,903,138
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $463.1K · FY2005–14$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,903,138 · 9
By mechanism
R01$1,621,815 · 1
R21$693,511 · 2
P20$419,309 · 4
S10$131,475 · 1
M01$37,028 · 1
Top collaborators
- Randall Walter Burt1 shared
Most similar at Emory University
Same institution · by research overlap
- Samuel C Dudley$19,023,025
- Ighovwerha Ofotokun$45,259,838
Others in their field
Top investigators on “Mutant”
- Kc Kent Lloyd · University Of California At Davis$103,993,616
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Bruce A Beutler · Ut Southwestern Medical Center$34,438,453
- Oscar A. Carretero · Henry Ford Health System$33,594,856
- Stuart H Orkin · Children'S Hospital Boston$33,454,343
- Tracy T Batchelor · Dana-Farber Cancer Inst$31,851,614
Research focus
MutantGene ExpressionMessenger RnaFutureMalignant NeoplasmsAthymic MouseNeoplasm /Cancer GeneticsGenesTissue /Cell CultureColonEpitheliumTissuesBreastProtein Structure FunctionProteinsSpecimenMonitorMrna Transcript DegradationBreast NeoplasmsNeoplastic CellBaseEpitheliomaFluorescent Dye /ProbeGene Expression Profile
Grant awards (19)
Molecular Phenotype of Polyps in Serrated Polyposis Syndrome$155,595
R21 · FY2014 · CA · contact PI
Molecular Phenotype of Polyps in Serrated Polyposis Syndrome$194,608
R21 · FY2013 · CA · contact PI
Sentinel Pol II RNAs for Measuring RNA Integrity in Biospecimens$124,707
R21 · FY2012 · CA · contact PI
Sentinel Pol II RNAs for Measuring RNA Integrity in Biospecimens$218,601
R21 · FY2011 · CA · contact PI
Breast Cancer Biology of Translational De-repression$237,241
R01 · FY2008 · CA · contact PI
Breast Cancer Biology of Translational De-repression$237,108
R01 · FY2007 · CA · contact PI
PH III TRIAL DFMO & SULDINAC- DECREASE RECURRENCE ADENOMATOUS POLYPS IN COLON$37,028
M01 · FY2007 · RR · contact PI
Breast Cancer Biology of Translational De-repression$238,645
R01 · FY2006 · CA · contact PI
HCV NS5B POLYMERASE MUTATIONS: BIOLOGY/PHARMACOLOGY$74,277
P20 · FY2006 · RR · contact PI
COBRE: U OF KANSAS MEDICAL CTR: CORE D: PHENOTYPING CORE$58,843
P20 · FY2006 · RR · contact PI
Breast Cancer Biology of Translational De-repression$244,388
R01 · FY2005 · CA
HCV NS5B POLYMERASE MUTATIONS: BIOLOGY/PHARMACOLOGY$145,808
P20 · FY2005 · RR
HEPATITIS C VIRUS NS5B POLYMERASE$72,904
P20 · FY2005 · RR
Breast Cancer Biology of Translational De-repression$244,388
R01 · FY2004 · CA
HEPATITIS C VIRUS IN NS5B POLYMERASE$67,477
P20 · FY2004 · RR
Emory Medicine Laser Capture Microdissection Facility$131,475
S10 · FY2002 · RR
DISRUPTION OF CELL CYCLE GENES IN BREAST CANCER$194,003
R01 · FY2001 · CA
DISRUPTION OF CELL CYCLE GENES IN BREAST CANCER$35,885
R01 · FY2001 · CA
DISRUPTION OF CELL CYCLE GENES IN BREAST CANCER$190,157
R01 · FY2000 · CA